A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial
暂无分享,去创建一个
M. Kozal | K. H. Hullsiek | M. Dehlinger | Mary van den Berg-Wolf | R. MacArthur | R. Novak | G. Peng | Ying Xiang | Li Chen | B. Schmetter | Christopher Henely | M. V. D. Berg-Wolf